Improving cancer treatment with a new method that combines proton and photon radiation therapy
Novel Optimization Methods and Treatment Planning System for Clinically-Deliverable Truly-Hybrid Proton-Photon Radiotherapy
This study is exploring a new way to make cancer radiation treatment better by using two types of beams—proton and photon—together, which could help target tumors more accurately while protecting healthy tissue, so cancer patients might have a more effective and gentle treatment experience.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10918096 on NIH RePORTER |
What this research studies
This research investigates a novel approach to cancer radiotherapy that combines proton and photon beams to enhance treatment effectiveness. By optimizing the delivery of these two types of radiation, the goal is to improve tumor targeting while minimizing damage to surrounding healthy tissues. The study aims to develop a treatment planning system that allows for better integration of proton and photon therapies, potentially leading to improved outcomes for cancer patients. Patients receiving this treatment may benefit from a more precise and effective radiation therapy experience.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who require radiotherapy and could benefit from a hybrid approach to treatment.
Not a fit: Patients who are not undergoing radiotherapy or those with conditions that do not require radiation treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments that better target tumors while protecting healthy organs.
How similar studies have performed: Previous research has shown promise in combining different types of radiation therapies, suggesting that this approach could lead to significant advancements in cancer treatment.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Gao, Hao — University of Kansas Medical Center
- Study coordinator: Gao, Hao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.